Humanistic burden of disease for patients with advanced melanoma in Canada
- PMID: 29322243
- PMCID: PMC5919988
- DOI: 10.1007/s00520-017-4025-9
Humanistic burden of disease for patients with advanced melanoma in Canada
Abstract
Background: Metastatic melanoma is a highly aggressive cancer, often striking in the prime of life. This study provides new information directly from advanced melanoma (stage III and IV) patients on how their disease impacts their health-related quality of life (HRQL).
Methods: Twenty-nine in-depth, qualitative interviews were conducted with adult patients with advanced melanoma in Canada. A semi-structured interview guide was used. Interviews were transcribed verbatim and key concepts were identified using a grounded theory analytic approach.
Results: Many patients' journeys began with the startling diagnosis of an invasive disease and a vastly shortened life expectancy. By the time they reached an advanced stage of melanoma, these patients' overall functioning and quality of life had been greatly diminished by this quickly progressing cancer. The impact was described in terms of physical pain and disability, emotional distress, diminished interactions with friends and family, and burden on caregivers.
Conclusion: Our findings provide evidence of signs, symptoms, and functional impacts of advanced melanoma. Signs and symptoms reported (physical, mental, and social) confirm and expand on those reported in the existing clinical literature. Primary care physicians should be better trained to identify melanomas early. Oncology care teams can improve on their current approaches for helping patients navigate treatment options, with information about ancillary services to mitigate disease impacts on HRQL, such as mental health and social supports, as well as employment or financial support services.
Keywords: Burden of disease; Cancer; Health-related quality of life; Melanoma; Patient interviews; Qualitative.
Conflict of interest statement
Made possible through the support of Merck Canada Inc. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of Merck Canada Inc.
References
-
- Ryerson AB, Eheman CR, Altekruse SF, Ward JW, Jemal A, Sherman RL, Henley SJ, Holtzman D, Lake A, Noone AM, Anderson RN, Ma J, Ly KN, Cronin KA, Penberthy L, Kohler BA. Annual report to the nation on the status of cancer, 1975–2012, featuring the increasing incidence of liver cancer. Cancer. 2016;122(9):1312–1337. doi: 10.1002/cncr.29936. - DOI - PMC - PubMed
-
- Canadian Cancer Society’s Advisory Committee on Cancer Statistics . Canadian cancer statistics 2016. Toronto: Canadian Cancer Society; 2016.
-
- National Cancer Institute SEER Cancer Stat Facts: Melanoma of the Skin. https://seer.cancer.gov/statfacts/html/melan.html. Accessed 23 Feb 2017
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical